- How To
- Cigar Info
- Site Info
Currently viewing the tag: "fda"
Lauren Lempert listened in to the presentations and scientific discussion of the RJR application to market Camel Snus as a modified (i.e., reduced) risk tobacco product on September 14, 2018. After that session, she and I prepared this public comment, wh
The new program, called “The Real Cost” Youth E-Cigarette Prevention Campaign, is targeted at the nearly 11 million at-risk teens, aged 12 to 17. The effort will include digital, social media and school ads. “The new campaign we’re announcing today seek
A scientific advisory committee of the [FDA] approved advancing the applications for six Camel Snus styles to the agency. The styles are Frost, Frost Large, Mellow, Mint, Robust and Winterchill. Snus, which became popular first in Sweden, are teabag-lik
Here at The Daily Free Press, many of our Interrobang answers in our print issues riff on the fact that freshmen are addicted to “Juuling,”… Let’s do the same thing with Juuls that we did with cigarettes — make them less cool.
We should continue to restrict sales of all tobacco-related products to minors, and more heavily tax the highest risk products. The FDA should amend its regulatory scheme from one designed to eliminate entry of any fundamentally new product into the mark
Earlier this year it was announced that the U.S. Food and Drug Administration (FDA) would begin to review British American Tobacco, Plc.’s (BAT) modified risk application for Camel Snus. Camel Snus is a smokeless tobacco pouch that BAT argued was a safer alternative to traditional cigarettes [read more here]. Camel Snus is made by Reynolds […]
The post FDA Not Sold on Reynolds’ Camel Snus Modified-Risk Claims appeared first on Tobacco Business Magazine.
Submit comments including data, research, and other related information to docket FDA-2017-N-4678-0001. There is currently no deadline for public comments. There may be conflicting deadlines added on regulations.gov and federalregister.gov. While we cann
On September 14, 2018, FDA filed for substantive scientific review one Modified Risk Tobacco Product (MRTP) Application from U.S. Smokeless Tobacco Company for its Copenhagen Snuff Fine Cut, a moist snuff smokeless tobacco product.
Camel Snus/ R.J. Reynolds Tobacco Company TBD FDA-2017-N-4678 September 13-14, 2018 / FDA is making these applications available for public comment in accordance with applicable laws. FDA will post the application materials, including current and future
advanced R.J. Reynolds Tobacco Company’s efforts to communicate reduced-risk information to consumers regarding its Camel Snus products…(TPSAC) recognized that the available science supports that switching completely from cigarettes to Camel Snus can si
- Steelers have bigger problems than Brown September 18, 2018
- Week 3 Fantasy Kicker Rankings: Can you replace Greg the leg? September 18, 2018
- Waiver Wire: Week 3 September 18, 2018
- TOUR Championship Odds and Best Bets September 18, 2018
- Hue Jackson didn't know Zane Gonzalez was kicking while injured Sunday September 18, 2018